| Source HCPCS Code |
|
Target NDC Code |
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00069-5410-66
VISTARIL 25 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2002 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00069-5420-66
VISTARIL 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00069-5440-93
VISTARIL 25 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
3/7/2007 |
| Number Of Items In Ndc Package |
480 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00069-5440-97
VISTARIL 25 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/11/2006 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00115-1803-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
04/23/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00115-1803-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
03/20/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
00115-1804-01
HYDROXYZINE PAM 50 MG CAP
|
| Detail Information |
| Relationship Start Date |
01/11/2017 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00115-1804-02
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
12/03/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00172-2911-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
4/10/2006 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00172-2911-70
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
4/10/2006 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00182-1098-89
HYDROXYZINE PAMOATE (10X10) 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
4/10/2006 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00185-0613-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/29/2014 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00185-0613-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/29/2014 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00185-0615-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00185-0615-05
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
00185-0674-01
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
00185-0674-05
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00185-0676-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
09/13/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00185-0676-05
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
09/13/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-1049-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00223-1049-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00364-0483-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
2/7/2002 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00364-0483-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
4/2/2002 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00555-0302-02
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00555-0302-04
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00555-0323-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2002 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00555-0323-04
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2002 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00555-0324-02
HYDROXYZINE PAMOATE 100 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00591-0800-01
HYDROXYZINE PAMOATE (USP) 25 MG
|
| Detail Information |
| Relationship Start Date |
9/18/2006 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00591-0800-05
HYDROXYZINE PAMOATE (USP) 25 MG
|
| Detail Information |
| Relationship Start Date |
9/18/2006 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00591-0801-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00591-0801-05
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00591-5726-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
2/13/2002 |
| Relationship End Date |
8/1/2005 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00591-5726-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
9/27/2005 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00615-0331-53
HYDROXYZINE PAMOATE (31X10,CARDED) 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
10/31/2003 |
| Number Of Items In Ndc Package |
31 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00615-0331-63
HYDROXYZINE PAMOATE (31X10) 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
10/31/2003 |
| Number Of Items In Ndc Package |
31 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00677-0596-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
4/15/2002 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-0362-40
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
3/3/2003 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-0362-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
3/3/2003 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-0362-61
HYDROXYZINE PAMOATE (10X10) 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
11/13/2002 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-6617-61
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
06/11/2018 |
| Relationship End Date |
04/24/2025 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-7065-61
HYDROXYZINE PAMOATE (10X10) 25 MG
|
| Detail Information |
| Relationship Start Date |
10/05/2020 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-7378-40
HYDROXYZINE HCL (USP,FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
10/16/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-7378-80
HYDROXYZINE HCL (USP,FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
10/16/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
10135-0811-01
HYDROXYZINE HCL FILM-COATED 25 MG
|
| Detail Information |
| Relationship Start Date |
04/01/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
10135-0811-10
HYDROXYZINE HCL FILM-COATED 25 MG
|
| Detail Information |
| Relationship Start Date |
04/01/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
10544-0328-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2008 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
11534-0205-01
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
07/03/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
11534-0205-03
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
07/03/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
11534-0205-04
hydrOXYzine HCl FILM-COATED 25 MG
|
| Detail Information |
| Relationship Start Date |
02/02/2026 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
12280-0205-04
VISTARIL 25 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
6/29/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
14539-0674-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
06/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
14539-0674-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
06/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
14539-0675-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
06/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
14539-0675-05
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
06/01/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16571-0114-01
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
10/12/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16571-0114-10
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
10/12/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16571-0114-50
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
10/12/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16590-0357-09
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2006 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
9 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16590-0357-12
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2006 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
12 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16590-0357-20
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2006 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16590-0357-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/1/2006 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
21695-0573-20
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
8/14/2008 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
21695-0573-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
8/14/2008 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
23490-5733-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
2/7/2007 |
| Relationship End Date |
1/1/2013 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
23490-5733-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
2/7/2007 |
| Relationship End Date |
1/1/2013 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
33358-0182-20
HYDROXYZINE PAM 25 MG
|
| Detail Information |
| Relationship Start Date |
07/10/2007 |
| Relationship End Date |
04/01/2020 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
33358-0182-30
HYDROXYZINE PAM 25 MG
|
| Detail Information |
| Relationship Start Date |
07/10/2007 |
| Relationship End Date |
04/01/2020 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
42291-0406-50
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
04/13/2018 |
| Relationship End Date |
08/30/2021 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
42291-0406-90
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
04/13/2018 |
| Relationship End Date |
06/30/2021 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
42291-0407-50
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
04/13/2018 |
| Relationship End Date |
09/30/2021 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
49452-3659-01
HYDROXYZINE PAMOATE (U.S.P./N.F.)
|
| Detail Information |
| Relationship Start Date |
06/01/2015 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
GM |
| Ndc Package Type |
BO |
| Route Of Administration |
NA |
| Billing Units |
GM |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
49452-3659-02
HYDROXYZINE PAMOATE (U.S.P./N.F.)
|
| Detail Information |
| Relationship Start Date |
06/01/2015 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
GM |
| Ndc Package Type |
BO |
| Route Of Administration |
NA |
| Billing Units |
GM |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
50268-0398-11
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
06/01/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
50268-0398-50
HYDROXYZINE PAMOATE AVPAK (5X10) 25 MG
|
| Detail Information |
| Relationship Start Date |
04/14/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
50268-0399-11
HYDROXYZINE PAM 50 MG CAP
|
| Detail Information |
| Relationship Start Date |
06/01/2021 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
50268-0399-50
HYDROXYZINE PAMOATE AVPAK (5X10) 50 MG
|
| Detail Information |
| Relationship Start Date |
04/14/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0077-01
HYDROXYZINE PAMOATE (USP) 25 MG
|
| Detail Information |
| Relationship Start Date |
11/26/2007 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0077-20
HYDROXYZINE PAMOATE (10X10) 25 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2002 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0078-01
HYDROXYZINE PAMOATE (USP) 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0078-20
HYDROXYZINE PAMOATE (10X10) 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51552-0979-04
HYDROXYZINE PAMOATE (U.S.P.)
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
1/1/2015 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
GM |
| Ndc Package Type |
BO |
| Route Of Administration |
NA |
| Billing Units |
GM |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51655-0533-52
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
6/22/2005 |
| Relationship End Date |
11/16/2012 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51927-2316-00
HYDROXYZINE PAMOATE (U.S.P.)
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
GM |
| Ndc Package Type |
JR |
| Route Of Administration |
NA |
| Billing Units |
GM |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52544-0800-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
10/1/2002 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52544-0800-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
10/1/2002 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0433-10
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
6/6/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0433-15
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
2/28/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0433-20
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
12/27/2004 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0433-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
10/17/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0433-40
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
40 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0433-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
12/27/2004 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0833-06
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52959-0833-20
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-2353-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
6/10/2003 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-2353-03
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2003 |
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-2353-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-2571-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-0169-01
VISTARIL 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-1854-00
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-1854-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-1854-03
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-1854-04
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-2892-00
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-2892-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-2892-03
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
9/19/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-2892-04
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
10/11/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-00
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-02
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-03
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
40 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-06
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-08
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-1661-09
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-04
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
7/1/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
9 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
3/24/2003 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-06
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-07
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
3/1/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-08
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
2/1/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-2195-09
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
12/6/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55289-0226-10
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55289-0226-15
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
3/6/2008 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55289-0354-10
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55887-0422-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
4/1/2004 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55887-0422-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
3/23/2007 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57866-3893-01
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
4/15/2002 |
| Relationship End Date |
5/25/2011 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57866-3893-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
4/15/2002 |
| Relationship End Date |
5/25/2011 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57866-3893-03
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
4/15/2002 |
| Relationship End Date |
5/25/2011 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-00
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-10
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-20
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-50
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0259-90
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
59651-0500-01
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
04/18/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
59651-0500-05
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
04/18/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
59651-0500-99
HYDROXYZINE HCL (FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
03/07/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
59762-5420-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
07/15/2020 |
| Relationship End Date |
08/31/2025 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
60432-0150-16
HYDROXYZINE 10 MG/5 ML SOLN
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
07/31/2024 |
| Number Of Items In Ndc Package |
473 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BOTTLE |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FORUSE AS A COMPLETE THERAP
|
⇄
|
60687-0696-01
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
11/30/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FORUSE AS A COMPLETE THERAP
|
⇄
|
60687-0696-11
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
11/30/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FORUSE AS A COMPLETE THERAP
|
⇄
|
60687-0707-01
HYDROXYZINE PAM 50 MG CAP
|
| Detail Information |
| Relationship Start Date |
05/25/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FORUSE AS A COMPLETE THERAP
|
⇄
|
60687-0707-11
HYDROXYZINE PAM 50 MG CAP
|
| Detail Information |
| Relationship Start Date |
05/25/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FORUSE AS A COMPLETE THERAP
|
⇄
|
60687-0707-65
HYDROXYZINE PAM 50 MG CAP
|
| Detail Information |
| Relationship Start Date |
05/25/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-31
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
31 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-32
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
32 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-39
HYDROXYZINE PAMOATE (BLISTER PACK) 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-45
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
45 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-51
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-54
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
2000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-90
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
61392-0123-91
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
7/27/2006 |
| Number Of Items In Ndc Package |
10000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0574-05
HYDROXYZINE HCL (USP,FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
04/19/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0574-12
HYDROXYZINE HCL (USP,FILM-COATED) 25 MG
|
| Detail Information |
| Relationship Start Date |
04/18/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0816-12
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
02/14/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0817-12
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
02/14/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62927-0621-04
HYDROXYZINE PAMOATE (BANANA) 25 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/17/2015 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
EA |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62927-0621-16
HYDROXYZINE PAMOATE (BANANA) 25 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2002 |
| Relationship End Date |
12/17/2015 |
| Number Of Items In Ndc Package |
480 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
EA |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63629-1533-01
HYDROXYYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
11/1/2004 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63629-1533-02
HYDROXYYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
11/1/2004 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63629-1856-01
HYDROXYYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
11/01/2004 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63629-1856-02
HYDROXYYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
11/01/2004 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-02
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
05/11/2004 |
| Relationship End Date |
04/01/2020 |
| Number Of Items In Ndc Package |
1000 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-03
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
05/11/2004 |
| Relationship End Date |
04/01/2020 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-04
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-05
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-09
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
9 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-10
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-14
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
14 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-15
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-20
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-25
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
25 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-28
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
28 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-40
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
40 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-45
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
45 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0442-90
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/11/2004 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-01
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-04
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-10
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-15
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-20
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-21
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
21 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-24
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
24 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-28
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
28 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-30
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-60
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63874-0757-90
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0208-20
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
10/22/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0208-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
10/22/2004 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
67046-0281-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
10/1/2002 |
| Relationship End Date |
8/1/2004 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
NA |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
68084-0847-01
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
02/24/2015 |
| Relationship End Date |
11/28/2024 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, fo...
|
⇄
|
68084-0847-11
HYDROXYZINE PAM 25 MG CAP
|
| Detail Information |
| Relationship Start Date |
02/24/2015 |
| Relationship End Date |
11/28/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
BLIST PACK |
| Route Of Administration |
PO |
| Billing Units |
CAP |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0177-00
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
5/5/2004 |
| Relationship End Date |
4/1/2009 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0177-30
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
3/17/2004 |
| Relationship End Date |
4/1/2009 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68115-0177-60
HYDROXYZINE PAMOATE 25 MG
|
| Detail Information |
| Relationship Start Date |
10/1/2003 |
| Relationship End Date |
4/1/2009 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68387-0468-30
HYDROXYZINE PAMOATE 50 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0177
HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68387-0469-30
HYDROXYZINE PAMOATE 100 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2014 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|